ActiveSC409098Private limited companyEdinburgh

EULYSIS UK LIMITED

Significant control: Keith John Morris (25–50%), Fig Equity LLP (25–50%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Coming soon · product and service lists

What does Eulysis UK Limited sell?

Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

EULYSIS UK LIMITED is an active private limited company (company number SC409098) incorporated on 10 October 2011, registered in Edinburgh. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest micro accounts cover the period ending 31 October 2025, showing net assets of −£342k, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 48% on the prior period (−£652k).

Peer position · net assets

By net assets it sits in the bottom quarter of 661 comparable companies in the UK (median £265, upper quartile £89k).

02

Ownership and control

2 active · 2 other
  • Mr Keith John Morris
    Individual · since 6 April 2016
    • holds 25–50% of voting rights
  • Fig Equity Llp
    corporate entity, England And Wales · since 1 December 2019
    • owns 25–50% of shares
    • holds 25–50% of voting rights
  • Mr Spyridon-Edouard Tsakas
    Individual · since 6 April 2016 · ceased 17 June 2022
    • owns 25–50% of shares
  • persons with significant control statement · since 10 October 2016 · ceased 9 October 2017

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
10 October 201115 yrs ago
Next accounts due
31 July 2027in 281 days
Confirmation statement due
24 October 2027in 366 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 21100
Manufacture of basic pharmaceutical products
Accounts type
Micro Entity
Size band
MicroCompanies Act thresholds
05

Financials

2 periods on record · latest ending 31 October 2025
Net assets
−£342k
vs Oct 2024
Cash at bank
Not reported
Turnover
Not disclosed
Employees
1
No changevs Oct 2024
Net assets
−£342k
Average employees
1
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 October 2025−£342k——£290k——1
31 October 2024−£652k——£604k——1
Current ratio0Current assets ÷ creditors within one year

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets below zeroNet assets £-341,951 at 31 October 2025
  • Net assets up 10% or more on the prior period+47.6% vs prior period
  • Current assets below creditors within one yearCurrent ratio 0.0
  • Incorporated five or more years agoIncorporated 10 October 2011

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Confirmation statement duein 366 days
  2. Next accounts duein 281 days
  3. Accounts period endNet liabilities £342k · micro accounts
  4. Accounts period endNet liabilities £652k · micro accounts
  5. Incorporated
08

Similar companies in Edinburgh

Same activity (manufacture of basic pharmaceutical products), closest in incorporation date
09

Reminders for EULYSIS UK LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.